NanoPalm
PrivateLast Round
Accelerator
Jun 19, 2025
Company Overview
NanoPalm is a biotechnology company that develops AI-designed patterned lipid nanoparticle (pLNP) delivery systems for gene and drug therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoPalm Comparables
Compare NanoPalm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mana.bio | 88% | |
| Liberate Bio | 80% | |
| Entos Pharmaceuticals | 76% | |
NanoPalm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 19, 2025 | ||||
| Accelerator | Apr 29, 2025 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2025
Grew 183% QoQ, from 6 to 17 employees.
- Jul 29, 2025
Grew 260% QoQ, from 5 to 18 employees.
NanoPalm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NanoPalm's valuation, stock price, and market status.